Project Grant 2429344
Award Date
1/15/25
Completion Date
12/31/25
Dollars Obligated
$275K
Federal Agency
National Science Foundation
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94107, USA
Similar Awards
This $275,000 Small Business Innovation Research (SBIR) Phase I grant, awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program, aims to develop new bacterial hosts for the productive secretion of difficult-to-express proteins. The project, led by Wild Microbes Co, a for-profit organization in Cambridge, MA, seeks to engineer improved bacterial strains that can manufacture proteins found in detergents, personal care products, and...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Seia Bio Inc. aims to develop a generalized process for formulating and stabilizing beneficial microbes to enable their widespread commercial adoption. The proposed R&D will advance the understanding of microbial protection against common stressors like heat, UV-light, shock, and humidity, by measuring physicochemical properties and viability. This innovative...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 supports the development of an automated, AI-supported platform for rapid detection of food pathogens. The key products/services to be delivered include: Building an automated sample preparation module to enhance pathogen enrichment across food groups. Developing an automated experimental design workflow to accelerate the optimization of enrichment time. Using...
This National Science Foundation (NSF) SBIR Phase I award to Foragr Medicines, Inc. provides $275,000 to develop a high-throughput platform for small molecule targeting of undruggable proteins via their mRNAs. The project aims to create an efficient and cost-effective approach to discover new therapeutics for previously untreatable diseases, including neurodegenerative conditions and aggressive cancers. Key innovations include automating ligand screening against mRNA targets and enabling...
The National Science Foundation (NSF) awarded a $275,000 Phase I Small Business Innovation Research (SBIR) grant under the NSF Technology, Innovation, and Partnerships (TIP) Program (CFDA 47.084) to Mvmnt-X, Inc., a small disadvantaged business located in Menlo Park, CA. The project aims to develop new optical methods and illumination techniques to improve the productivity of microalgae cultivation systems for the capture of carbon dioxide and other pollutants generated by agricultural...
This $275,000 Small Business Innovation Research (SBIR) Phase I grant was awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084). The project aims to develop and validate a modular technology that leverages microwaves and electromagnetic fields to enhance the efficiency of anaerobic digestion for generating biogas from organic waste by at least 20%. The broader impact of this effort is to contribute to climate change...
New Horizon Biotech Inc. received a $256,000 National Science Foundation SBIR Phase I Project Grant to determine performance characteristics during cultivation of living organisms in a novel single-use horizontal modular and pressurizable microbial fermentor. The funding period is from February 15, 2021 through May 31, 2023 under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084). This program seeks to advance science, engineering, and technology innovations to address...
The National Science Foundation (NSF) awarded a $274,980 Phase I Small Business Innovation Research (SBIR) grant to Cisterna Biologics, Inc. under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084). The project aims to develop a novel platform technology for cost-efficient production of high-quality messenger RNA (mRNA) in yeast. The broader impact of this research is to revolutionize mRNA manufacturing by transforming yeast cells into efficient mRNA factories, using...
This $275,000 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program supports the development of a label-free, high-resolution, high-throughput protein screening platform called Vibrational Spectroscopy with Metasurface Optics (VISMO). The technology aims to enable simultaneous, minute-scale measurement of millions of protein samples, which would dramatically improve the lengthy and costly cycles...
This SBIR Phase I award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program provides $273,111 to Hoofprint Biome, Inc. to develop a probiotic yeast technology that can reduce methane emissions from cattle by at least 30%, and potentially up to 98%. The technology involves screening and optimizing enzymes that restrict methane production in the cattle rumen, and then packaging these enzymes for delivery via a probiotic yeast. The...